closing auction shenanigans.., page-7

they’re low on cash IF they don’t close a paid pilot/commercial agreement soon and clearly those are the big focus from them right now. If they close some deals and need extra cash to fuel growth then a CR will be a gift to people who take it up.

As for the low price.. this is a tiny spec of a health/medtech speculative company who has some great promise but not a lot of runs on the board so is completely overlooked. Share price is part of the equation but so too is volume. The volumes on HMD are really really tightening which means that people are holding their shares not dumping them from fear. From where it was a few months ago the share price is up, where it was in April it’s more than double, where it is relative to the IPO looks down but allowing for CR dilution it hasn’t really changed all that much. From its highest price it’s down heaps. Depends on perspective as to wether it’s low or not. At 13.5 my position is just in the green.

If you look at the Chairman Ron’s other ventures Capital Raisings work well long term. I think there’s bigger things on the horizon for little HMD